Age-related macular degeneration and recent developments: new hope for old eyes?

Brid Morris, Fraser Imrie, Ana-Maria Armbrecht, Baljean Dhillon

Research output: Contribution to journalLiterature reviewpeer-review


Age-related macular degeneration (AMD) is the commonest cause of blindness in the population over 60 years of age and accounts for over 50% of those registered blind in the UK. The incidence is increasing and as older generations live longer a growing number of patients will be affected in the future. Affected patients lose central vision, important in all aspects of everyday life. This review outlines risk factors for AMD, clinical features, treatment and management strategies for patients, families and physicians caring for those with AMD. Recent trials are included along with practical clinical advice. While there is no curative treatment at present, intervention can reduce the risk of developing AMD and limit disease progression if it occurs. These modalities are discussed here. As new discoveries in the field of genetics and novel therapies emerge, a brighter future seems certain for the ageing population.
Original languageEnglish
Pages (from-to)301-7
Number of pages7
JournalPostgraduate Medical Journal
Issue number979
Publication statusPublished - May 2007


Dive into the research topics of 'Age-related macular degeneration and recent developments: new hope for old eyes?'. Together they form a unique fingerprint.

Cite this